Ceftibuten

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

INDICATIONS

INDICATIONS

FDA

FDA

FDA

  • Acute exacerbation of chronic bronchitis (AECB) caused by H. influenzae, M. catarrhalis or S. pneumoniae (penicillin-susceptible strains)
  • Otitis media caused by H. influenzae, M. catarrhalis or S. pyogenes
  • Pharyngitis and tonsillitis caused by S. pyogenes

NON-FDA APPROVED USES

NON-FDA APPROVED USES

NON-FDA APPROVED USES

  • Community acquired pneumonia

There's more to see -- the rest of this topic is available only to subscribers.

© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.